NCT01181700View on ClinicalTrials.gov

A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood After Dosing With Oral Inhalation From Dry Powder Inhalers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Pharmacokinetics
Interventions
DRUG

Treatment A

PF-00241939 300 ug using inhaler A

DRUG

Treatment B

PF-00241939 300 ug using inhaler A

DRUG

Treatment C

PF-00241939 300 ug using inhaler A

DRUG

Treatment D

PF-00241939 300 ug using inhaler B

DRUG

Treatment E

PF-00241939 300 ug using inhaler B

DRUG

Treatment F

PF-00241939 300 ug using inhaler B

DRUG

Treatment G

PF-00241939 300 ug using inhaler B

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY